[LABP] YoY Quarter Result on 31-Dec-2021 [#Q4]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
24-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -59.45%
YoY- -77.21%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 0 0 -18,000 0 0 -
PBT -6,119 -5,232 -20,097 -11,341 -3,508 14.91%
Tax 1,002 -1,352 320 -437 160 58.14%
NP -6,119 -3,880 -20,097 -11,341 -3,508 14.91%
Tax Rate - - - - - -
Total Cost 6,119 3,880 2,097 11,341 3,508 14.91%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin 0.00 0.00 111.65 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -0.99 -0.96 -5.20 -2.90 -1.08 -2.15%
EPS Diluted -0.99 -0.96 -5.20 -2.90 -1.08 -2.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.